We further surveyed CD166 expression on human prostate cancer tissue microarrays, which consist of 14 castration resistant (CRPC) metastasis samples and 98 hormone naïve primary cancer samples from patients receiving either neoadjuvant hormone treatment (NHT) for various periods or receiving no treatment. Here, ALCAM is linked to cancer.